Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ, Sandborn WJ, Tremaine WJ. Egan LJ, et al. Am J Gastroenterol. 1998 Mar;93(3):442-8. doi: 10.1111/j.1572-0241.1998.00442.x. Am J Gastroenterol. 1998. PMID: 9517654 Clinical Trial.
Gastrointestinal radiation injury: prevention and treatment.
Shadad AK, Sullivan FJ, Martin JD, Egan LJ. Shadad AK, et al. Among authors: egan lj. World J Gastroenterol. 2013 Jan 14;19(2):199-208. doi: 10.3748/wjg.v19.i2.199. World J Gastroenterol. 2013. PMID: 23345942 Free PMC article. Review.
Positioning novel biologic, probiotic, and apheresis therapies for Crohn's disease and ulcerative colitis.
Egan LJ, Sandborn WJ. Egan LJ, et al. Curr Gastroenterol Rep. 2005 Dec;7(6):485-91. doi: 10.1007/s11894-005-0080-3. Curr Gastroenterol Rep. 2005. PMID: 16313879 Review.
Pharmacogenomics in inflammatory bowel disease.
Egan LJ, Derijks LJ, Hommes DW. Egan LJ, et al. Clin Gastroenterol Hepatol. 2006 Jan;4(1):21-8. doi: 10.1016/j.cgh.2005.10.003. Clin Gastroenterol Hepatol. 2006. PMID: 16431300 Review.
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis.
O'Connell J, Rowan C, Stack R, Harkin G, Parihar V, Chan G, Breslin N, Cullen G, Dunne C, Egan L, Harewood G, Leyden J, MacCarthy F, MacMathuna P, Mahmud N, McKiernan S, McNamara D, Mulcahy H, Murray F, O'Connor A, O'Toole A, Patchett S, Ryan B, Sheridan J, Slattery E, Doherty G, Kevans D. O'Connell J, et al. Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1019-1026. doi: 10.1097/MEG.0000000000001177. Eur J Gastroenterol Hepatol. 2018. PMID: 29878945
Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexate.
Egan LJ, Sandborn WJ, Mays DC, Tremaine WJ, Lipsky JJ. Egan LJ, et al. Inflamm Bowel Dis. 1999 Aug;5(3):167-73. doi: 10.1097/00054725-199908000-00004. Inflamm Bowel Dis. 1999. PMID: 10453372
Drug therapy of inflammatory bowel disease.
Egan LJ, Sandborn WJ. Egan LJ, et al. Drugs Today (Barc). 1998 May;34(5):431-46. doi: 10.1358/dot.1998.34.5.485242. Drugs Today (Barc). 1998. PMID: 15010706
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
Egan LJ, Tremaine WJ, Mays DC, Lipsky JJ, Sandborn WJ. Egan LJ, et al. Inflamm Bowel Dis. 2000 Nov;6(4):286-9. doi: 10.1002/ibd.3780060406. Inflamm Bowel Dis. 2000. PMID: 11149561
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis.
Egan LJ, Sandborn WJ, Tremaine WJ, Leighton JA, Mays DC, Pike MG, Zinsmeister AR, Lipsky JJ. Egan LJ, et al. Aliment Pharmacol Ther. 1999 Dec;13(12):1597-604. doi: 10.1046/j.1365-2036.1999.00667.x. Aliment Pharmacol Ther. 1999. PMID: 10594394 Clinical Trial.
Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease.
Egan LJ, Sandborn WJ, Mays DC, Tremaine WJ, Fauq AH, Lipsky JJ. Egan LJ, et al. Clin Pharmacol Ther. 1999 Jan;65(1):29-39. doi: 10.1016/S0009-9236(99)70119-0. Clin Pharmacol Ther. 1999. PMID: 9951428
84 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback